A detailed history of Tower Bridge Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Tower Bridge Advisors holds 65,590 shares of PFE stock, worth $1.84 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
65,590
Previous 64,027 2.44%
Holding current value
$1.84 Million
Previous $1.78 Billion 3.29%
% of portfolio
0.2%
Previous 0.18%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$25.26 - $29.6 $39,481 - $46,264
1,563 Added 2.44%
65,590 $1.84 Billion
Q1 2024

Apr 29, 2024

SELL
$25.89 - $29.73 $62,136 - $71,352
-2,400 Reduced 3.61%
64,027 $1.78 Billion
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $77,083 - $100,123
-2,950 Reduced 4.25%
66,427 $1.91 Billion
Q3 2023

Nov 01, 2023

BUY
$32.09 - $37.51 $121,909 - $142,500
3,799 Added 5.79%
69,377 $2.3 Billion
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $4.1 Million - $4.75 Million
-113,601 Reduced 63.4%
65,578 $2.41 Billion
Q1 2023

Apr 26, 2023

SELL
$39.39 - $51.28 $15,362 - $19,999
-390 Reduced 0.22%
179,179 $7.31 Billion
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $109,356 - $133,496
-2,499 Reduced 1.37%
179,569 $7.86 Billion
Q2 2022

Jul 21, 2022

SELL
$46.53 - $55.17 $254,798 - $302,110
-5,476 Reduced 2.92%
182,068 $9.55 Billion
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $101,931 - $126,305
-2,228 Reduced 1.17%
187,544 $9.71 Billion
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $33,056 - $49,000
-800 Reduced 0.42%
189,772 $11.2 Billion
Q3 2021

Oct 28, 2021

SELL
$39.25 - $50.42 $20,802 - $26,722
-530 Reduced 0.28%
190,572 $8.2 Billion
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $189,568 - $214,749
5,279 Added 2.84%
191,102 $7.48 Billion
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $341,363 - $384,989
-10,193 Reduced 5.2%
185,823 $6.73 Billion
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $911,622 - $1.16 Million
27,237 Added 16.14%
196,016 $7.22 Billion
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $35,083 - $41,161
-1,105 Reduced 0.65%
168,779 $6.19 Billion
Q1 2020

Apr 27, 2020

SELL
$27.03 - $38.62 $39,680 - $56,694
-1,468 Reduced 0.86%
169,884 $5.55 Billion
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $707,681 - $803,127
-21,497 Reduced 11.15%
171,352 $6.71 Billion
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $46,298 - $60,035
-1,425 Reduced 0.73%
192,849 $7.15 Billion
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $1,146 - $1,287
31 Added 0.02%
194,274 $8.42 Billion
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $187,650 - $206,164
5,004 Added 2.64%
194,243 $8.25 Billion
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $419,515 - $478,293
-10,905 Reduced 5.45%
189,239 $8.26 Billion
Q3 2018

Oct 23, 2018

SELL
$34.47 - $41.81 $33,952 - $41,182
-985 Reduced 0.49%
200,144 $8.82 Billion
Q2 2018

Aug 09, 2018

SELL
$32.98 - $35.16 $25,988 - $27,706
-788 Reduced 0.39%
201,129 $7.3 Billion
Q1 2018

May 02, 2018

SELL
$31.91 - $37.02 $183,131 - $212,457
-5,739 Reduced 2.76%
201,917 $7.17 Billion
Q4 2017

Jan 30, 2018

BUY
$33.26 - $35.29 $4,456 - $4,728
134 Added 0.06%
207,656 $7.52 Billion
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $6.43 Million - $7.09 Million
207,522
207,522 $7.41 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $158B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Tower Bridge Advisors Portfolio

Follow Tower Bridge Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.